Cover Image

TNFα blockers and infectious risk in rheumatoid arthritis

Patients suffering from rheumatoid arthritis have increased risk of infections when compared with general population. The risk depends directly from disease activity and severity. Furthermore, risk increases with aging, immunosuppressive agents and comorbidities such as diabetes, pulmonary and cardi...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. Todesco (Author), P. Sfriso (Author), A. Montante (Author), L. Bernardi (Author), F. Ometto (Author), C. Botsios (Author), B. Raffeiner (Author), L. Punzi (Author)
Format:	Book
Published:	PAGEPress Publications, 2011-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis
by: S. Todesco, et al.
Published: (2011)

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects
by: C. Botsios, et al.
Published: (2003)

Incidence and management of infusion reactions to infliximab in 186 italian patient's with rheumatoid arthritis: the Padua experience
by: S. Todesco, et al.
Published: (2011)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
by: Cynthia Said, et al.
Published: (2013)

TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results
by: M. Fabris, et al.
Published: (2002)

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab
by: L. Punzi, et al.
Published: (2011)

Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients
by: F. Cacciapaglia, et al.
Published: (2016)

Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature
by: M. Di Franco, et al.
Published: (2011)

Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis
by: C. Salvarani, et al.
Published: (2004)

Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor Therapy
by: Anna Szeremeta, et al.
Published: (2024)

T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy
by: Sonja Dulic, et al.
Published: (2017)

Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy
by: Yijun Chen, et al.
Published: (2023)

The Role of Anti-TNFα Therapy in the Amelioration of Disease Burden in Patients with Refractory Rheumatoid Arthritis
by: Madha Mohammed Sheet, et al.
Published: (2014)

RITUXIMAB EFFICACY IN TREATING SYSTEMIC JUVENILE ARTHRITIS REFRACTORY TO TRADITIONAL IMMUNOSUPPRESSANT AND TNF BLOCKER THERAPY
by: E.I. Alexeeva, et al.
Published: (2007)

RITUXIMAB EFFICACY IN TREATING SYSTEMIC JUVENILE ARTHRITIS REFRACTORY TO TRADITIONAL IMMUNOSUPPRESSANT AND TNF BLOCKER THERAPY
by: E.I. Alexeeva, et al.
Published: (2007)

Serum Level of TNF-α and IL-17 in Patient Have Chronic Periodontitis Associated Rheumatoid Arthritis
by: Munir Nasr Hamed, et al.
Published: (2017)

QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
by: R.V. Denisova, et al.
Published: (2009)

EXPERIENCE OF ADMINISTRATION OF SOLUBLE RECEPTORS TO TNF-α IN PATIENT WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: T.M. Bzarova, et al.
Published: (2010)

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment
by: C. Leonetti, et al.
Published: (2011)

QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
by: R.V. Denisova, et al.
Published: (2009)

EXPERIENCE OF ADMINISTRATION OF SOLUBLE RECEPTORS TO TNF-α IN PATIENT WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: T.M. Bzarova, et al.
Published: (2010)

Expression of TNF-α and Related Signaling Molecules in the Peripheral Blood Mononuclear Cells of Rheumatoid Arthritis Patients
by: Sunil Kumar Raghav, et al.
Published: (2006)

Recommendations for starting anti TNF-α in patients with ankylosing spondylitis
by: L. Olivieri, et al.
Published: (2003)

Potential significance of changes in serum levels of IL-17, TNF-α and DKK-1 in the progression of the rheumatoid arthritis
by: Qunxia Wang, et al.
Published: (2023)

GOLIMUMAB - A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012)

Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis
by: F. R. Spinelli, et al.
Published: (2013)

Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking
by: Liang Liang Bai, et al.
Published: (2021)

IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive
by: Margot Bongenaar, et al.
Published: (2020)

Farmacoeconomic impact of anti-TNFα
by: E. Vaccaro, et al.
Published: (2011)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
by: Salmaso A, et al.
Published: (2008)

Genetic Polymorphism in TNF-α Promoter Region: Its Association with Severity and Susceptibility to Rheumatoid Arthritis in Iraqi Patients with Active Disease
by: khalid abdulhussein abdulameer, et al.
Published: (2023)

Ultrasound Detection of Septic Arthritis in a Rheumatoid Arthritis Patient on Anti-TNF Treatment
by: Anupama C. Nandagudi MSc, MRCP (UK), et al.
Published: (2014)

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
by: R. Caporali, et al.
Published: (2011)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
by: Fragoulakis V, et al.
Published: (2015)

Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis
by: Vicente Escudero-Vilaplana, et al.
Published: (2012)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
by: Delphine Dénarié, et al.
Published: (2017)

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis
by: M. Maset, et al.
Published: (2011)

IL-1β and TNFα Promote Monocyte Viability through the Induction of GM-CSF Expression by Rheumatoid Arthritis Synovial Fibroblasts
by: Christelle Darrieutort-Laffite, et al.
Published: (2014)

EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsin, et al.
Published: (2009)

EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsin, et al.
Published: (2009)